(NASDAQ:SAGT), KUALA LUMPUR, Malaysia, July 01, 2025 (GLOBE NEWSWIRE) — Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a leading provider of customizable enterprise software solutions, today announced the signing of a US$10 million smart hospitality technology agreement with SMD Tech – FZCO, a UAE-based digital infrastructure firm. This major win represents a pivotal […]

Sagtec Global (NASDAQ: SAGT) Accelerates Middle East Expansion with US$10 Million Smart Hospitality Tech Deal in UAE Strategic Partnership with SMD Tech Signals Sagtec's Entry into the US$30B Smart Tourism Sector; 60% of Contract Value is Multi-Year Recurring Revenue GlobeNewswire July 01, 2025 KUALA LUMPUR, Malaysia, July 01, 2025 (GLOBE NEWSWIRE) — Sagtec Global Limited

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said today that it completed the previously announced agreement to acquire Inozyme Pharma, Inc. (Nasdaq: INZY) for $4.00 per share in an all-cash transaction worth approximately $270 million. The acquisition will strengthen BioMarin's enzyme therapies portfolio, adding a late-stage enzyme replacement therapy, INZ-701. The medicine is currently being developed for

This Notice provides information about the sources of the Fund's monthly distributions. You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's Managed Distribution Plan. https://mma.prnewswire.com/media/1839719/Allspring_Logo.jpg The Fund estimates that it has distributed more than its income and net realized capital

(Other OTC:ETST),(OTC US:ETST), Miami, FL, July 01, 2025 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring, optimizing, and scaling high-potential operating businesses, is pleased to announce its qualification for and listing on the newly launched OTCID tier of the OTC Markets. The OTCID

(NASDAQ:GRI), Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety results demonstrated GRI-0621 to be safe and well-tolerated in the first 12 and 24 patients evaluated, respectively Results on track for 6-week interim biomarker

(NASDAQ:WLDS),(NASDAQ:WLDSW), YOKNEAM ILLIT, ISRAEL, July 01, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (AI)-powered touchless sensing wearable devices, today announced that it will exhibit at the Fifth XR Fair Tokyo (XR Fair Tokyo), to be held at the Tokyo

Earth Science Tech, Inc. Qualifies for and Joins New OTCID Tier GlobeNewswire July 01, 2025 Miami, FL, July 01, 2025 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring, optimizing, and scaling high-potential operating businesses, is pleased to announce its qualification for and listing

GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”) GlobeNewswire July 01, 2025 Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety results demonstrated GRI-0621

Wearable Devices to Showcase Mudra Link, Its Established AI-Based Neural Wristband for Smart Glasses, at XR Fair Tokyo 2025 GlobeNewswire July 01, 2025 YOKNEAM ILLIT, ISRAEL, July 01, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in artificial intelligence (AI)-powered touchless sensing wearable